Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
UNITED KINGDOM – Pharmaceutical and healthcare giant GlaxoSmithKline (GSK) has opened a new aseptic smart manufacturing facility at its Barnard Castle site, representing an investment of more than £90 million…
Read More
UNITED KINGDOM – Pharmaceutical company GSK has revealed a rebrand, as it refocuses its efforts in the area of “biopharma innovation.” London-based consultancy Wolff Olins is behind the new look,…
Read More
USA – US Food and Drug administration (US FDA) has approved GSK’s Priorix (Measles, Mumps, and Rubella Vaccine Live) for individuals at least 1 year old. MMR vaccines are recommended…
Read More
UNITED KINGDOM – Pfizer plans to sell its 32% stake in Haleon, its consumer health venture with British drugmaker GSK, after the business lists as an independent company in July,…
Read More
SWITZERLAND – GlaxoSmithKline’s ViiV Healthcare has committed to grant voluntary license on the patents for its injectable HIV prevention drug to make it more widely available in poorer nations, where…
Read More
UNITED KINGDOM – GSK has announced a definitive agreement to acquire Affinivax for up to US$3.3 billion, including a US$2.1 billion upfront payment, with potential milestone payments of up to…
Read More
URUGUAY – GlaxoSmithKline (GSK) announced the opening of one of its “three new regional vaccine distribution centers” in Uruguay during President Luis Lacalle Pou’s visit to London. In the next…
Read More
USA –GSK announced that the US Food and Drug Administration has approved a new drug application for daprodustat for people with chronic kidney disease (CKD) who also have anemia. GSK…
Read More
UNITED KINGDOM – GlaxoSmithKline (GSK) sought to strengthen its cancer business on Wednesday by agreeing to a US$1.9 billion deal to acquire US drug developer Sierra Oncology, the latest move…
Read More
GERMANY –CureVac and GlaxoSmithKline have signed on to a German pandemic contingency plan to reserve mRNA production capacity for years to come as they take another stab at a second-generation…
Read More